231 related articles for article (PubMed ID: 29427144)
1. Outcomes of synchronous and metachronous bilateral small renal masses (< 4 cm): a population-based cohort study.
Sheikh NA; Khan MH; Pillai S; Lang S; Nabi G
Int Urol Nephrol; 2018 Apr; 50(4):657-663. PubMed ID: 29427144
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic Features and Prognosis of Sporadic Bilateral Renal Cell Carcinoma: A Series of 148 Cases.
Qi N; Li T; Ning X; Peng X; Cai L; Gong K
Clin Genitourin Cancer; 2017 Oct; 15(5):618-624. PubMed ID: 28648756
[TBL] [Abstract][Full Text] [Related]
3. Bilateral renal cancers: oncological and functional outcomes.
Berczi C; Thomas B; Bacso Z; Flasko T
Int Urol Nephrol; 2016 Oct; 48(10):1617-22. PubMed ID: 27379623
[TBL] [Abstract][Full Text] [Related]
4. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
[TBL] [Abstract][Full Text] [Related]
5. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
6. Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy.
Simhan J; Canter DJ; Sterious SN; Smaldone MC; Tsai KJ; Li T; Viterbo R; Chen DY; Greenberg RE; Kutikov A; Uzzo RG
J Urol; 2013 Jan; 189(1):43-7. PubMed ID: 23164383
[TBL] [Abstract][Full Text] [Related]
7. Bilateral Wilms' tumor: Mansoura multi-centers 15 years experience.
Halim A; Elashry R; Soliman O; Sarhan O
J Oncol Pharm Pract; 2012 Mar; 18(1):115-21. PubMed ID: 22235062
[TBL] [Abstract][Full Text] [Related]
8. Bilateral renal masses: pathologic concordance and impact of temporal presentation.
Arnoux V; Fiard G; Descotes JL; Rambeaud JI; Long JA
Minerva Urol Nefrol; 2012 Dec; 64(4):287-93. PubMed ID: 23288216
[TBL] [Abstract][Full Text] [Related]
9. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
[TBL] [Abstract][Full Text] [Related]
10. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
11. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
12. Impact of multiple deprivations on detection, progression and interventions in small renal masses (less than 4 cm) in a population based study.
Leonard M; Tait CD; Gillan AS; Rai BP; Byrne DJ; Nabi G;
Eur J Surg Oncol; 2013 Oct; 39(10):1157-63. PubMed ID: 23886896
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
14. Synchronous Bilateral RCC Is Associated With Poor Recurrence-Free Survival Compared With Unilateral RCC: A Single-Center Study With Propensity Score Matching Analysis.
Kim JK; Lee H; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
Clin Genitourin Cancer; 2019 Jun; 17(3):e570-e580. PubMed ID: 30922860
[TBL] [Abstract][Full Text] [Related]
15. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
[TBL] [Abstract][Full Text] [Related]
16. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma.
Furtwängler R; Schmolze M; Gräber S; Leuschner I; Amann G; Schenk JP; Niggli F; Kager L; von Schweinitz D; Graf N
Klin Padiatr; 2014 May; 226(3):175-81. PubMed ID: 24819388
[TBL] [Abstract][Full Text] [Related]
18. Active surveillance for selected patients with renal masses: updated results with long-term follow-up.
Abou Youssif T; Kassouf W; Steinberg J; Aprikian AG; Laplante MP; Tanguay S
Cancer; 2007 Sep; 110(5):1010-4. PubMed ID: 17628489
[TBL] [Abstract][Full Text] [Related]
19. Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF; Brunot A; Pladys A; Bouzille G; Dagher J; Medane S; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Edeline J; Laguerre B; Lespagnol A; Mosser J; Dugay F; Belaud-Rotureau MA; Rioux-Leclercq N
Clin Genitourin Cancer; 2017 Feb; 15(1):e1-e7. PubMed ID: 27444986
[TBL] [Abstract][Full Text] [Related]
20. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
